Robot‐assisted vs open inferior vena cava thrombectomy: a comparative analysis of perioperative and oncological outcomes

OBJECTIVES: To compare the perioperative and oncological outcomes between open inferior vena cava (IVC) thrombectomy (OP-IVCT) and robot-assisted IVCT (RA-IVCT) for renal tumours with Mayo levels I-IV IVC thrombi. PATIENTS AND METHODS: We retrospectively evaluated patients who underwent radical nephrectomy with IVCT between January 2006 and December 2023 at a high-volume centre. The patients were stratified according to the surgical approach (OP-IVCT vs RA-IVCT). Primary analysis was performed in the full cohort using multivariable regression models, with surgical approach as a covariate. The key perioperative outcomes, postoperative complications, disease-free survival (DFS), and overall survival (OS) were evaluated. Propensity score matching (PSM) at a one-to-one ratio was performed as a sensitivity analysis. RESULTS: Of the 226 patients, 37 underwent OP-IVCT and 189 underwent RA-IVCT. In the full-cohort multivariable analyses, RA-IVCT was independently associated with lower estimated blood loss (adjusted ratio 0.472, P < 0.001), shorter postoperative hospital stay (adjusted ratio 0.798, P = 0.027), reduced intraoperative transfusion (adjusted odds ratio [OR] 0.065, P = 0.002), and fewer postoperative complications (adjusted OR 0.162, P = 0.007). The operative time and intensive care unit transfer did not differ significantly between the groups. The surgical approach was not independently associated with OS (adjusted hazard ratio [HR] 1.019, P = 0.969) or DFS (adjusted HR 0.782, P = 0.528). After PSM, 37 matched pairs were analysed. The matched analysis confirmed lower estimated blood loss, reduced transfusion requirement, shorter hospital stay, and fewer postoperative complications with RA-IVCT, whereas OS and DFS remained statistically comparable between the groups. CONCLUSION: RA-IVCT is a safe and effective alternative to OP-IVCT for patients with renal tumours and IVC tumour thrombi. No evidence of inferior intermediate-term oncological outcomes was observed for RA-IVCT.

Authors

Institutions

Publication Details

Journal
British Journal of Urology
Published
2026-11-13
DOI
https://doi.org/10.1111/bju.70542
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Robot‐assisted vs open inferior vena cava thrombectomy: a comparative analysis of perioperative and oncological outcomes

Liangyou Gu, Qilong Jiao, Qingbo Huang, Jialong Song et al.
4 links
British Journal of Urology
Renal cell carcinoma treatment
article

Robot‐assisted vs open inferior vena cava thrombectomy: a comparative analysis of perioperative and oncological outcomes

Liangyou Gu, Qilong Jiao, Qingbo Huang, Jialong Song, Xu Zhang, Xin Ma, Xinlin Peng, Teng Su, Xinran Chen, Jiayi Chen, Chenzhi Zhao, Cheng Peng, Yibo Chen, Xuanyu Bai, Changwei Shi
article en

Abstract

OBJECTIVES: To compare the perioperative and oncological outcomes between open inferior vena cava (IVC) thrombectomy (OP-IVCT) and robot-assisted IVCT (RA-IVCT) for renal tumours with Mayo levels I-IV IVC thrombi. PATIENTS AND METHODS: We retrospectively evaluated patients who underwent radical nephrectomy with IVCT between January 2006 and December 2023 at a high-volume centre. The patients were stratified according to the surgical approach (OP-IVCT vs RA-IVCT). Primary analysis was performed in the full cohort using multivariable regression models, with surgical approach as a covariate. The key perioperative outcomes, postoperative complications, disease-free survival (DFS), and overall survival (OS) were evaluated. Propensity score matching (PSM) at a one-to-one ratio was performed as a sensitivity analysis. RESULTS: Of the 226 patients, 37 underwent OP-IVCT and 189 underwent RA-IVCT. In the full-cohort multivariable analyses, RA-IVCT was independently associated with lower estimated blood loss (adjusted ratio 0.472, P < 0.001), shorter postoperative hospital stay (adjusted ratio 0.798, P = 0.027), reduced intraoperative transfusion (adjusted odds ratio [OR] 0.065, P = 0.002), and fewer postoperative complications (adjusted OR 0.162, P = 0.007). The operative time and intensive care unit transfer did not differ significantly between the groups. The surgical approach was not independently associated with OS (adjusted hazard ratio [HR] 1.019, P = 0.969) or DFS (adjusted HR 0.782, P = 0.528). After PSM, 37 matched pairs were analysed. The matched analysis confirmed lower estimated blood loss, reduced transfusion requirement, shorter hospital stay, and fewer postoperative complications with RA-IVCT, whereas OS and DFS remained statistically comparable between the groups. CONCLUSION: RA-IVCT is a safe and effective alternative to OP-IVCT for patients with renal tumours and IVC tumour thrombi. No evidence of inferior intermediate-term oncological outcomes was observed for RA-IVCT.

British Journal of Urology
Nankai University (CN), Chinese PLA General Hospital (CN)
National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation
Good health and well-being
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon